Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

or shortness of breath, but who had no concerning historical or clinical features for PE and a feasible alternative diagnosis (such as lower respiratory tract infection). The committee noted that the studies evaluating PERC all took place in emergency departments. But they could see no reason why its use should be limited to this setting or why the diagnostic accuracy of PERC would differ in other settings such as outside of the hospital. They reiterated that it was the experience of diagnosing PE that was important for applying the rule as opposed to the setting. People with COVID-19 are considered to have a higher risk of VTE than the general population, and risk increases with severity of disease. The committee discussed that the PERC rule may not be suitable to rule out PE in people with COVID-19 because of the increased risk of VTE in this population. However, they also acknowledged that the tool has not been validated in this population. Taken together, the committee wanted to raise awareness around the use of PERC in the COVID-19 population. How the recommendation might affect practice The PERC rule is not widely used in current practice. This recommendation is expected to increase
